Resultados da busca - Denis Soulières

Refinar Resultados
  1. 1
    The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements

    The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements por Pierre-Olivier Gaudreau, John Stagg, Denis Soulières, Fred Saad

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Mutations in NSCLC and their link with lung cancer-associated thrombosis: A case-control study

    Mutations in NSCLC and their link with lung cancer-associated thrombosis: A case-control study por Luis Corrales, Denis Soulières, Xiaoduan Weng, Mustapha Tehfé, Marie Florescu, Normand Blais

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects

    Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects por Christian Kollmannsberger, Denis Soulières, Ralph Wong, Alissa Scalera, Rania Gaspo, Georg A. Bjarnason

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

    Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the He... por Denis Soulières, Neil Senzer, Everett E. Vokes, Manuel Hidalgo, Sanjiv S. Agarwala, Lillian L. Siu

    Publicado em 2003
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Neutrophil count is associated with survival in localized prostate cancer

    Neutrophil count is associated with survival in localized prostate cancer por Houda Bahig, Daniel Taussky, Guila Delouya, Amal Nadiri, Ariane Gagnon-Jacques, Paule Bodson‐Clermont, Denis Soulières

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Clinical outcomes in non‐small‐cell lung cancer patients with <i>EGFR</i> mutations: pooled analysis

    Clinical outcomes in non‐small‐cell lung cancer patients with <i>EGFR</i> mutations: pooled analysis por Luis Paz‐Ares, Denis Soulières, I. Melezínek, Joachim Moecks, Lorenz Keil, Tony Mok, Rafael Rosell, Barbara Klughammer

    Publicado em 2010
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  7. 7
    Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab

    Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab por Fanny Zulay Acero Brand, Nicolas Suter, Jean‐Philippe Adam, B Faulques, Antonio Maietta, Denis Soulières, Normand Blais

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    KRAS Mutation Testing in the Treatment of Metastatic Colorectal Cancer with Anti-EGFR Therapies

    KRAS Mutation Testing in the Treatment of Metastatic Colorectal Cancer with Anti-EGFR Therapies por Denis Soulières, Wenda Greer, Anthony M. Magliocco, David G. Huntsman, Sean Young, Ming‐Sound Tsao, Suzanne Kamel‐Reid

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review

    Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review por Aly‐Khan A. Lalani, Daniel Y.C. Heng, Naveen S. Basappa, Lori Wood, Nayyer Iqbal, Deanna McLeod, Denis Soulières, Christian Kollmannsberger

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  10. 10
    Gastrointestinal Stromal Tumours: Consensus Statement on Diagnosis and Treatment

    Gastrointestinal Stromal Tumours: Consensus Statement on Diagnosis and Treatment por Martin E. Blackstein, Jean‐Yves Blay, Christopher L. Corless, David K. Driman, Robert H. Riddell, Denis Soulières, Carol J. Swallow, Shailendra Verma

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer

    Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer por Hope S. Rugo, Alison Stopeck, Anil A. Joy, Stephen Chan, Shailendra Verma, Aña Lluch, Katherine Liau, Sinil Kim, Paul Bycott, Brad Rosbrook, Angel H. Bair, Denis Soulières

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1

    Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1 por Denis Soulières, Lisa Licitra, Ricard Mesı́a, Éva Remenár, Shau-Hsuan Li, А. А. Карпенко, Marie Chol, Ying A. Wang, Nadia Solovieff, Laurence Bourdeau, Dalila Sellami, Sandrine Faivre

    Publicado em 2018
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

    Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040) por Sara I. Pai, Sandrine Faivre, Lisa Licitra, Jean-Pascal Machiels, Jan B. Vermorken, Paolo Bruzzi, Viktor Gruenwald, R. Giglio, C. René Leemans, Tanguy Y. Seiwert, Denis Soulières

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Phase I/II Trial of Erlotinib and Cisplatin in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Princess Margaret Hospital Phase II Consortium and National Cancer Institute of Canada Clinical Trials Group Study

    Phase I/II Trial of Erlotinib and Cisplatin in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Princess Margaret Hospital Phase II Consortium... por Lillian L. Siu, Denis Soulières, Eric X. Chen, Gregory R. Pond, Soo Chin, P. Francis, Luc Harvey, M. Klein, Wenjiang Zhang, Janet Dancey, Elizabeth A. Eisenhauer, Eric Winquist

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer

    Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer por Kenneth Emancipator, Lingkang Huang, Deepti Aurora-Garg, Tricia Bal, Ezra E.W. Cohen, Kevin J. Harrington, Denis Soulières, Christophe Le Tourneau, Lisa Licitra, Barbara Burtness, Ramona F. Swaby

    Publicado em 2020
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells

    Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells por Robert H. Vonderheide, Patricia LoRusso, Magi Khalil, Elaina M. Gartner, Divis Khaira, Denis Soulières, Prudence Dorazio, Jennifer A. Trosko, Jens Rüter, G Mariani, Tiziana Usari, Susan M. Domchek

    Publicado em 2010
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115

    Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical... por J. Maroun, K. Bélanger, Lesley Seymour, S. Matthews, James Roach, Jeanne Dionne, Denis Soulières, David J. Stewart, Rakesh Goel, Danielle Charpentier, Glenwood Goss, Eva Tomiak, J. Yau, José Jimeno, G. Chiritescu

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol

    Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol por Nada J. Farsi, Marie‐Claude Rousseau, Nicolas F. Schlecht, Geneviève Castonguay, Paul Allison, Phuc Félix Nguyen‐Tan, Denis Soulières, François Coutlée, Michael Hier, Sreenath Madathil, Eduardo L. Franco, Belinda Nicolau

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma

    Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma por Carole Fakhry, Qiang Zhang, Phuc Félix Nguyen‐Tan, David I. Rosenthal, Adel K. El‐Naggar, Adam S. Garden, Denis Soulières, Andy Trotti, Vilija N. Avizonis, John A. Ridge, Jonathan Harris, Quynh‐Thu Le, Maura L. Gillison

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma

    Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma por Houda Bahig, F. Aubin, John Stagg, Olguta Gologan, Olivier Ballivy, Éric Bissada, Felix‐Phuc Nguyen‐Tan, Denis Soulières, Louis Guertin, Édith Filion, Apostolos Christopoulos, Louise Lambert, Mustapha Tehfé, Tareck Ayad, Danielle Charpentier, Rahima Jamal, Philip Wong

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: